INTERNAL PREVIEW — this page describes a product in development. Nothing here is approved for publication. Items marked TBC must be confirmed before this page goes live.

HomeProductsalveoNeo

In development · Next-generation FOT platform

alveoNeoname TBC

A handheld forced-oscillometry device with an on-device touchscreen, patient management and guided test control — oscillometry without a cart or a PC.

Availability, regulatory status and specifications TBC

The handheld alveoNeo forced-oscillometry device

What it does

Capabilities described in the system requirements specification. Performance figures are not yet defined.

Handheld, self-contained

A pistol-grip form factor with its own touchscreen, so the test happens at the patient rather than the patient coming to a cart.

On-device patient management

Register patients on the device, maintain a local patient database, and synchronise the patient list with the platform.

Guided FOT test control

Start and stop test functions with command-control, acquisition and packet creation handled on the device.

On-board DSP

Signal processing and FFT on the device, producing pressure, flow, resistance (Rrs), reactance (Xrs) and coherence.

Works online or standalone

Access-point and station network modes, so the device operates where there is no reliable connection and syncs later.

Device and provider registration

Registration flow binding the device to a provider, with first-boot setup and factory reset.

Result reporting

Final averaging and structured result output, ready for the connected platform.

How it fits the platform

alveoNeo is designed to join the same record every other alveofit device writes to.

CapturealveoNeo

FOT acquisition and on-device DSP, with patient context already on the device.

InterpretalveoMD®

Review, grading and interpretation alongside spirometry and existing oscillometry results.

ConnectalveoConnect®

Population analytics, and ABDM-consented filing into the patient's ABHA record. See the platform

Specifications

The requirements specification does not yet define numeric performance limits. These must be supplied by engineering before publication.

Product nameTBC — "alveoNeo" is provisional (TBD-001)
MethodForced Oscillation Technique with on-device DSP/FFT
Reported outputsPressure, Flow, Rrs, Xrs, Coherence
Frequency rangeTBC
Sampling / acquisitionTBC
Accuracy & reproducibilityTBC
Validated age rangeTBC
ConnectivityWi-Fi access-point and station modes; cloud sync
StorageOn-device patient and test database capacity TBC
Regulatory statusTBC — no clearance or approval claimed
Availability & priceTBC

Not included on this page, deliberately: authentication and token handling, encryption key management, API endpoints and schemas, the authorisation matrix, and device factory-reset internals. Those are in the internal SRS and should not be public.

Interested in alveoNeo?

Tell us about your setting and we will get in touch when it is ready to demonstrate.

Register interest →